Although these findings will require confirmation in additional, independent tumor cohorts, our results indicate the feasibility and utility of IHC staining for MYC that can be implemented as part of the standard diagnostic evaluation of DLBCL. Here, MYC is linked to diffuse large B-cell lymphoma.